日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor-tyrosine kinase inhibitor resistance subclones.

对难治性肺癌进行纵向药物基因组学分析,以确定表皮生长因子受体酪氨酸激酶抑制剂耐药亚克隆的治疗候选药物

Yu Namhee, Hwang Mihwa, Ahn Beung Chul, Lee Youngjoo, Hong Sehwa, Sim Hanna, Song Bo Ram, Kim Sunshin, Park Charny, Han Ji-Youn

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer

VEGF信号复杂性导致EGFR酪氨酸激酶抑制剂耐药的非小细胞肺癌对阿特珠单抗、贝伐珠单抗、卡铂和紫杉醇产生耐药性

Hong, Sehwa; Yu, Namhee; Cho, Ju Young; Lee, Geon Kook; Ahn, Beung-Chul; Lee, Youngjoo; Sim, Hanna; Song, Bo Ram; Hwang, Mihwa; Kim, Sunshin; Kim, Jung-Hyun; Park, Charny; Han, Ji-Youn

Synthetic data-driven AI approach for fetal chromosomal aneuploidies detection

基于合成数据驱动的AI方法用于胎儿染色体非整倍体检测

Hwang, Changhoe; Adhikari, Krishna Prasad; Oh, Gyeongin; Kim, Sunshin

Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy

患者来源肺癌细胞的药物反应可预测靶向治疗的临床结果

Kim, Sunshin; Lee, Youngjoo; Song, Bo Ram; Sim, Hanna; Kang, Eun Hye; Hwang, Mihwa; Yu, Namhee; Hong, Sehwa; Park, Charny; Ahn, Beung-Chul; Lim, Eun Jin; Hwang, Kum Hui; Park, Seog-Yun; Choi, Jin-Ho; Lee, Geon Kook; Han, Ji-Youn

Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer

利用患者来源的细胞进行药物基因组学评估,揭示晚期肺癌的潜在耐药机制和新型疗法

Yu, Namhee; Hwang, Mihwa; Lee, Youngjoo; Song, Bo Ram; Kang, Eun Hye; Sim, Hanna; Ahn, Beung-Chul; Hwang, Kum Hui; Kim, Jihyun; Hong, Sehwa; Kim, Sunshin; Park, Charny; Han, Ji-Youn

Splicing signature database development to delineate cancer pathways using literature mining and transcriptome machine learning

利用文献挖掘和转录组机器学习技术构建剪接特征数据库,以阐明癌症通路。

Lee, Kyubin; Hyung, Daejin; Cho, Soo Young; Yu, Namhee; Hong, Sewha; Kim, Jihyun; Kim, Sunshin; Han, Ji-Youn; Park, Charny

Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance

铂类耐药小细胞肺癌的分子亚型及肿瘤微环境特征

Jihyun Kim, Sunshin Kim, Seog-Yun Park, Geon Kook Lee, Kun Young Lim, Jin Young Kim, Jung-Ah Hwang, Namhee Yu, Eun Hye Kang, Mihwa Hwang, Bo Ram Song, Charny Park, Ji-Youn Han

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2

BCAR4 致癌融合激活 EGFR 信号传导,并对 EGFR/HER2 的双重抑制敏感

Kieun Bae, Jin Hee Kim, Ja Young Lee, Sun-Young Kong, Yun-Hee Kim, Sunshin Kim, Kyong-Ah Yoon

MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report

MET扩增型非小细胞肺癌患者MYC扩增导致对卡马替尼产生原发性耐药:病例报告

Choi, Wonyoung; Jeong, Kyung-Chae; Park, Seog-Yun; Kim, Sunshin; Kang, Eun Hye; Hwang, Mihwa; Han, Ji-Youn

A fusion of CD63-BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis

在肺腺癌中发现的 CD63-BCAR4 融合促进致瘤性和转移

Kieun Bae, Jin Hee Kim, Hyojik Jung, Sun-Young Kong, Yun-Hee Kim, Sunshin Kim, Geon Kook Lee, Jin Soo Lee, Jake June-Koo Lee, Young Seok Ju, Yang-Kyu Choi, Kyong-Ah Yoon